mirella salvatore

Associate Professor

Weill Cornell Medical College

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mirella Salvatore is an Associate Professor at Weill Cornell Medical College in the United States. Her research focuses on immunology and infectious diseases, particularly in relation to SARS-CoV-2 and its variants. Recent publications include studies on the immune response to COVID-19, the role of soluble CD13 in thrombogenic inflammation, and the effects of interferon ɛ on Zika virus infection.

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

UNITED STATES

View details

Iwijn De Vlaminck

Associate Professor

Cornell University

UNITED STATES

View details

Woan-Yu Lin

Weill Cornell Medicine

UNITED STATES

View details

RosyPriya Kodiyanplakkal

Weill Cornell Medicine

UNITED STATES

View details

Eli Finkelsztein

Weill Cornell Medicine

UNITED STATES

View details

Robert DeSimone

Assistant Professor

Weill Cornell Medicine

UNITED STATES

View details

Ayana Morales

Assistant Professor

Weill Cornell Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

mirella salvatore

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.

Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals

Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections

Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice

Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19

Interferon ɛ restricts Zika virus infection in the female reproductive tract

Distinct temporal trajectories and risk factors for Post-acute sequelae of SARS-CoV-2 infection

Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors.

A metagenomic DNA sequencing assay that is robust against environmental DNA contamination

Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment

System-wide transcriptome damage and tissue identity loss in COVID-19 patients

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1

Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.

Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.

Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza

Remdesivir treatment for severe COVID-19 in third-trimester pregnancy: Case report and management discussion

Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir

Collaborators (11)

Jonathan Schisler

Charles Vorkas

Kohta Saito

Jiwoon Park

Paul Simonson

Iwijn De Vlaminck

Woan-Yu Lin

RosyPriya Kodiyanplakkal

Eli Finkelsztein

Robert DeSimone

Ayana Morales

Make your next move.